The safety of available treatments for chronic constipation

References

• Bharucha AE, Dorn SD, Lembo A, et al. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013;144(1):211–217.
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016. Doi: 10.1053/j.gastro.2016.02.031.
   Web of Science ®Google Scholar
• Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011;25(1):3–18.
   PubMed Web of Science ®Google Scholar
• Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007;25(5):599–608.
   PubMed Web of Science ®Google Scholar
• Rey E, Balboa A, Mearin F. Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences. Am J Gastroenterol. 2014;109(6):876–884.
   PubMed Web of Science ®Google Scholar
• Sanchez MI, Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol. 2011;25(Suppl):B:11b-5b.
   PubMedGoogle Scholar
• Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96(11):3130–3137.
   PubMed Web of Science ®Google Scholar
• Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33(6):818–824.
   PubMed Web of Science ®Google Scholar
• Emmanuel A, Quigley EM, Simren M, Feng Y, Muller-Lissner S, Urbain D, et al. Factors affecting satisfaction with treatment in European women with chronic constipation: an internet survey. United European Gastroenterol J. 2013;1(5):375–384.
   PubMed Web of Science ®Google Scholar
• Muller-Lissner S, Tack J, Feng Y, et al. Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey. Aliment Pharmacol Ther. 2013;37(1):137–145.
   PubMed Web of Science ®Google Scholar
• Rey E, Barcelo M, Jimenez Cebrian MJ, et al. A nation-wide study of prevalence and risk factors for fecal impaction in nursing homes. PloS One. 2014;9(8):e105281.
   PubMed Web of Science ®Google Scholar
• Bellini M, Usai-Satta P, Bove A, et al. Chronic constipation diagnosis and treatment evaluation: the “CHRO.CO.DI.T.E.” study. BMC Gastroenterol. 2017;17(1):11.
   PubMed Web of Science ®Google Scholar
• Bove A, Bellini M, Battaglia E, et al. Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). World J Gastroenterol: WJG. 2012;18(36):4994–5013.
   PubMed Web of Science ®Google Scholar
• Tack J, Muller-Lissner S, Stanghellini V, et al. Diagnosis and treatment of chronic constipation–a European perspective. Neurogastroenterol Motil. 2011;23(8):697–710.
   PubMed Web of Science ®Google Scholar
• Gattuso JM, Kamm MA. Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Safety. 1994;10(1):47–65.
   PubMed Web of Science ®Google Scholar
• Muller-Lissner S. What has happened to the cathartic colon? Gut. 1996;39(3):486–488.
   PubMed Web of Science ®Google Scholar
• Muller-Lissner SA. Adverse effects of laxatives: fact and fiction. Pharmacology. 1993;47(Suppl 1):138–145.
   PubMed Web of Science ®Google Scholar
• Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209–218.
   PubMed Web of Science ®Google Scholar
• Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut. 2000;46(4):522–526.
   PubMed Web of Science ®Google Scholar
• Corazziari E, Badiali D, Habib FI, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci. 1996;41(8):1636–1642.
   PubMed Web of Science ®Google Scholar
• Mueller-Lissner S, Kamm MA, Wald A, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol. 2010;105(4):897–903.
   PubMed Web of Science ®Google Scholar
• Kamm MA, Mueller-Lissner SA, Wald A, et al. Stimulant laxatives are effective in chronic constipation: multi-center, 4-week, double-blind, randomized, placebo-controlled trial of bisacodyl. Gastroenterology. 2010;138(Suppl 1):S228.
   Google Scholar
• Basilisco G, Marino B, Passerini L, et al. Abdominal distension after colonic lactulose fermentation recorded by a new extensometer. Neurogastroenterol Motil. 2003;15(4):427–433.
   PubMed Web of Science ®Google Scholar
• Lederle FA, Busch DL, Mattox KM, et al. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. Am J Med. 1990;89(5):597–601.
   PubMed Web of Science ®Google Scholar
• Di Palma JA, Cleveland MV, McGowan J, et al. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol. 2007;102(9):1964–1971.
   PubMed Web of Science ®Google Scholar
• Di Palma JA, Cleveland MV, McGowan J, et al. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther. 2007;25(6):703–708.
   PubMed Web of Science ®Google Scholar
• Attar A, Lemann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999;44(2):226–230.
   PubMed Web of Science ®Google Scholar
• Minguez M, Lopez Higueras A, Judez J. Use of polyethylene glycol in functional constipation and fecal impaction. Rev Esp Enferm Dig. 2016;108(12):790–806.
   PubMed Web of Science ®Google Scholar
• Nagarajan N, Morden A, Bischof D, et al.. The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2015;27(9):1002–1010.
   PubMed Web of Science ®Google Scholar
• Cheskin LJ, Kamal N, Crowell MD, et al. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc. 1995;43(6):666–669.
   PubMed Web of Science ®Google Scholar
• Fenn GC, Wilkinson PD, Lee CE, et al. A general practice study of the efficacy of regulan in functional constipation. Br J Clin Pract. 1986;40(5):192–197.
   PubMedGoogle Scholar
• Ashraf W, Park F, Lof J, et al. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther. 1995;9(6):639–647.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Liang XM, Yu ZL, et al. Controlled comparison of low-dose polyethylene glycol 3350 plus electrolytes with ispaghula husk in the treatment of adults with chronic functional constipation. Clin Drug Investig. 2004;24(10):569–576.
   PubMed Web of Science ®Google Scholar
• Passmore AP, Wilson-Davies K, Stoker C, et al. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ. 1993;307(6907):769–771.
   PubMed Web of Science ®Google Scholar
• Perkin JM. Constipation in childhood: a controlled comparison between lactulose and standardized senna. Curr Med Res Opin. 1977;4:540–543.
   PubMed Web of Science ®Google Scholar
• Pare P, Fedorak RN. Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation. Can J Gastroenterol Hepatol. 2014;28(10):549–557.
   PubMed Web of Science ®Google Scholar
• Obokhare I. Fecal impaction: a cause for concern? Clin Colon Rectal Surg. 2012;25(1):53–58.
   PubMedGoogle Scholar
• Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum. 2001;44(8):1201–1209.
   PubMed Web of Science ®Google Scholar
• Serrano Falcon B, Alvarez Sanchez A, Diaz-Rubio M, et al. Prevalence and factors associated with faecal impaction in the Spanish old population. Age Ageing. 2016.
   Web of Science ®Google Scholar
• Katelaris P, Naganathan V, Liu K, et al. Comparison of the effectiveness of polyethylene glycol with and without electrolytes in constipation: a systematic review and network meta-analysis. BMC Gastroenterol. 2016;16:42.
   PubMed Web of Science ®Google Scholar
• Szojda MM, Mulder CJ, Felt-Bersma RJ. Differences in taste between two polyethylene glycol preparations. J Gastrointestin Liver Dis. 2007;16(4):379–381.
   PubMed Web of Science ®Google Scholar
• Di Palma JA, Smith JR, Cleveland M. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol. 2002;97(7):1776–1779.
   PubMed Web of Science ®Google Scholar
• Weng YM, Chen SY, Chen HC, et al. Hypermagnesemia in a constipated female. J Emerg Med. 2013;44(1):e57–60.
   PubMed Web of Science ®Google Scholar
• [Cited 20 Apr 2017]. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm380757.htm). 04 Oct 2017.
   Google Scholar
• Nyberg C, Hendel J, Nielsen OH. The safety of osmotically acting cathartics in colonic cleansing. Nat Reviews Gastroenterol Hepatology. 2010;7(10):557–564.
   PubMed Web of Science ®Google Scholar
• Ainley EJ, Winwood PJ, Begley JP. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation. Dig Dis Sci. 2005;50(7):1319–1323.
   PubMed Web of Science ®Google Scholar
• Desmeules S, Bergeron MJ, Isenring P. Acute phosphate nephropathy and renal failure. N Engl J Med. 2003;349(10):1006–1007.
   PubMed Web of Science ®Google Scholar
• Harrison NM, Hjelkrem MC. Bowel cleansing before colonoscopy: balancing efficacy, safety, cost and patient tolerance. World J Gastrointest Endosc. 2016;8(1):4–12.
   PubMed Web of Science ®Google Scholar
• Yoon HE, Kim YW, Ha KS, et al. Hypermagnesemia accompanied with colonic perforation in a hemodialysis patient. Yonsei Med J. 2013;54(3):797–800.
   PubMed Web of Science ®Google Scholar
• Tatsumi H, Masuda Y, Imaizumi H, et al. A case of cardiopulmonary arrest caused by laxatives-induced hypermagnesemia in a patient with anorexia nervosa and chronic renal failure. J Anesth. 2011;25(6):935–938.
   PubMed Web of Science ®Google Scholar
• Khairi T, Amer S, Spitalewitz S, et al. Severe symptomatic hypermagnesemia associated with over-the-counter laxatives in a patient with renal failure and sigmoid volvulus. Case Reports Nephrol. 2014;2014:560746.
   PubMedGoogle Scholar
• Karahan MA, Kucuk A, Buyukfirat E, et al. Acute respiratory and renal failure due to hypermagnesemia, induced by counter laxatives in an elderly man. J Clin Diagn Res. 2015;9(12):Ul01.
   PubMedGoogle Scholar
• Tapia H, Mora C, Navarro JF. [Magnesium in chronic kidney disease]. Nefrologia. 2007;27(6):674–680.
   PubMed Web of Science ®Google Scholar
• Izdes S, Kesimci E, Kanbak O. Paralytic ileus as a complication of iatrogenic hypermagnesaemia without renal dysfunction. Anaesth Intensive Care. 2008;36(1):124.
   PubMed Web of Science ®Google Scholar
• Schorr M, Miller KK. The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Reviews Endocrinol. 2017;13(3):174–186.
   PubMed Web of Science ®Google Scholar
• Weir MA, Fleet JL, Vinden C, et al. Hyponatremia and sodium picosulfate bowel preparations in older adults. Am J Gastroenterol. 2014;109(5):686–694.
   PubMed Web of Science ®Google Scholar
• Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol. 2003;36(5):386–389.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. “Melanosis” in the small and large intestine. World J Gastroenterol: WJG. 2008;14(27):4296–4299.
   PubMed Web of Science ®Google Scholar
• Siegers CP, Von Hertzberg-Lottin E, Otte M, et al. Anthranoid laxative abuse–a risk for colorectal cancer? Gut. 1993;34(8):1099–1101.
   PubMed Web of Science ®Google Scholar
• Koskela E, Kulju T, Collan Y. Melanosis coli prevalence, distribution, histologic features 200 consecutive autopsies at Kuopio University Central Hospital. Diseases Colon Rectum. 1989;32(3):235–239.
   PubMed Web of Science ®Google Scholar
• Walker NI, Smith MM, Smithers BM. Ultrastructure of human melanosis coli with reference to its pathogenesis. Pathology. 1993;25(2):120–123.
   PubMed Web of Science ®Google Scholar
• Toyoda K, Nishikawa A, Furukawa F, et al. Cell proliferation induced by laxatives and related compounds in the rat intestine. Cancer Lett. 1994;83(1–2):43–49.
   PubMed Web of Science ®Google Scholar
• van Gorkom BA, Timmer-Bosscha H, de Jong S, van der Kolk DM, Kleibeuker JH, de Vries EG. Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. Br J Cancer. 2002;86(9):1494–1500.
   PubMed Web of Science ®Google Scholar
• Nishikawa A, Kase Y, Hayakawa T, et al. Enhancement of cell proliferation and prostaglandin biosynthesis by 1,8-dihydroxyanthraquinone in the rat large intestine. Carcinogenesis. 1997;18(6):1259–1263.
   PubMed Web of Science ®Google Scholar
• Kune GA. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Z Gastroenterol. 1993;31(2):140–143.
   PubMed Web of Science ®Google Scholar
• Nakamura GJ, Schneiderman LJ, Klauber MR. Colorectal cancer and bowel habits. Cancer. 1984;54(7):1475–1477.
   PubMed Web of Science ®Google Scholar
• Roberts MC, Millikan RC, Galanko JA, et al. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol. 2003;98(4):857–864.
   PubMed Web of Science ®Google Scholar
• Patel PM, Selby PJ, Deacon J, et al. Anthraquinone laxatives and human cancer: an association in one case. Postgrad Med J. 1989;65(762):216–217.
   PubMed Web of Science ®Google Scholar
• Khilnani GC, Hadda V. Lipoid pneumonia: an uncommon entity. Indian J Med Sci. 2009;63(10):474–480.
   PubMedGoogle Scholar
• Meltzer E, Guranda L, Vassilenko L, et al. Lipoid pneumonia: a preventable complication. Isr Med Assoc J: IMAJ. 2006;8(1):33–35.
   PubMed Web of Science ®Google Scholar
• Cornacchia DJ, Snyder CH, Dupont DC, et al. Exogenous lipoid pneumonia. J Am Osteopath Assoc. 1989;89(5):659–663.
   PubMed Web of Science ®Google Scholar
• Meltzer E, Guranda L, Perelman M, et al. Lipoid pneumonia: a preventable form of drug-induced lung injury. Eur J Intern Med. 2005;16(8):615–617.
   PubMedGoogle Scholar
• Midulla F, Strappini PM, Ascoli V, et al. Bronchoalveolar lavage cell analysis in a child with chronic lipid pneumonia. Eur Respir J. 1998;11(1):239–242.
   PubMed Web of Science ®Google Scholar
• Suhonen R, Kantola I, Bjorksten F. Anaphylactic shock due to ingestion of psyllium laxative. Allergy. 1983;38(5):363–365.
   PubMed Web of Science ®Google Scholar
• Zaloga GP, Hierlwimmer UR, Engler RJ. Anaphylaxis following psyllium ingestion. J Allergy Clin Immunol. 1984;74(1):79–80.
   PubMed Web of Science ®Google Scholar
• Vaswani SK, Hamilton RG, Valentine MD, et al. Psyllium laxative-induced anaphylaxis, asthma, and rhinitis. Allergy. 1996;51(4):266–268.
   PubMed Web of Science ®Google Scholar
• Sussman GL, Dorian W. Psyllium anaphylaxis. Allergy Proc. 1990;11(5):241–242.
   PubMedGoogle Scholar
• Seggev JS, Ohta K, Tipton WR. IgE mediated anaphylaxis due to a psyllium-containing drug. Ann Allergy. 1984;53(4):325–326.
   PubMedGoogle Scholar
• Lantner RR, Espiritu BR, Zumerchik P, et al. Anaphylaxis following ingestion of a psyllium-containing cereal. JAMA: Journal Am Med Assoc. 1990;264(19):2534–2536.
   PubMed Web of Science ®Google Scholar
• Khalili B, Bardana EJ Jr., Yunginger JW. Psyllium-associated anaphylaxis and death: a case report and review of the literature. Ann Allergy Asthma Immunol. 2003;91(6):579–584.
   PubMed Web of Science ®Google Scholar
• James JM, Cooke SK, Barnett A, et al. Anaphylactic reactions to a psyllium-containing cereal. J Allergy Clin Immunol. 1991;88(3 Pt 1):402–408.
   PubMed Web of Science ®Google Scholar
• Drake CL, Moses ES, Tandberg D. Systemic anaphylaxis after ingestion of a psyllium-containing breakfast cereal. Am J Emerg Med. 1991;9(5):449–451.
   PubMed Web of Science ®Google Scholar
• Lee SH, Hwang SH, Park JS, et al. Anaphylaxis to polyethylene glycol (Colyte(R)) in a patient with diverticulitis. J Korean Med Sci. 2016;31(10):1662–1663.
   PubMed Web of Science ®Google Scholar
• Soto Mera T, Filgueira JF, Villamil E. Linseed: a dangerous antigen. Rev Esp Alergol Inmunol Clín. 1998;13(6):362–363.
   Google Scholar
• Pahor M, Guralnik JM, Chrischilles EA, et al. Use of laxative medication in older persons and associations with low serum albumin. J Am Geriatr Soc. 1994;42(1):50–56.
   PubMed Web of Science ®Google Scholar
• Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet. 1991;337(8737):372–373.
   PubMed Web of Science ®Google Scholar
• Sipe HJ Jr., Corbett JT, Mason RP. In vitro free radical metabolism of phenolphthalein by peroxidases. Drug Metab Dispos. 1997;25(4):468–480.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Longnecker MP, Sandler DP, et al. Risk of ovarian cancer in relation to use of phenolphthalein-containing laxatives. Br J Cancer. 2000;83(3):404–406.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Longnecker MP, Peters RK. Ovarian cancer risk and use of phenolphthalein-containing laxatives. Pharmacoepidemiol Drug Saf. 2004;13(1):35–39.
   PubMed Web of Science ®Google Scholar
• Aboumarzouk OM, T A, R A, et al. Cisapride for intestinal constipation. Cochrane Database Syst Rev. 2011;(1):Cd007780.
   PubMed Web of Science ®Google Scholar
• Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35(7):745–767.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Piessevaux H, Yiannakou Y, et al. Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials. Dig Dis Sci. 2016;61(8):2357–2372.
   PubMed Web of Science ®Google Scholar
• Muller-Lissner S, Rykx A, Kerstens R, et al. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil. 2010;22(9):991–8, e255.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Beyens G, Kerstens R, et al. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009;21(12):1256–e117.
   PubMed Web of Science ®Google Scholar
• Mozaffari S, Nikfar S, Abdollahi M. Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients. Arch Med Sci. 2014;10(1):10–18.
   PubMed Web of Science ®Google Scholar
• Lembo AJ, Cremonini F, Meyers N, et al. Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study. Aliment Pharmacol Ther. 2010;31(9):979–990.
   PubMed Web of Science ®Google Scholar
• Layer P, Stanghellini V. Review article: linaclotide for the management of irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2014;39(4):371–384.
   PubMed Web of Science ®Google Scholar
• Johnston JM, Kurtz CB, Macdougall JE, et al. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology. 2010;139(6):1877–86.e2.
   PubMed Web of Science ®Google Scholar
• Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012;107(11):1702–1712.
   PubMed Web of Science ®Google Scholar
• Rao S, Lembo AJ, Shiff SJ, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol. 2012;107(11):1714-24; quiz p.25.
   Web of Science ®Google Scholar
• Rey E, Mearin F, Alcedo J, et al. Optimizing the use of linaclotide in patients with constipation-predominant irritable bowel syndrome: an expert consensus report. Adv Ther. 2017;34(3):587–598.
   PubMed Web of Science ®Google Scholar
• Izzy M, Malieckal A, Little E, et al. Review of efficacy and safety of laxatives use in geriatrics. World J Gastrointest Pharmacol Ther. 2016;7(2):334–342.
   PubMedGoogle Scholar
• Miner PB Jr., Koltun WD, Wiener GJ, et al. A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation. Am J Gastroenterol. 2017;112(4):613–621.
   PubMed Web of Science ®Google Scholar
• Methylnaltrexone: MNTX. Drugs R D. 2006;7(6):374–378.
   PubMedGoogle Scholar
• Viscusi ER, Barrett AC, Paterson C, et al. Efficacy and safety of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain: a placebo crossover analysis. Reg Anesth Pain Med. 2016;41(1):93–98.
   PubMed Web of Science ®Google Scholar
• Corsetti M, Tack J. Naloxegol, a new drug for the treatment of opioid-induced constipation. Expert Opin Pharmacother. 2015;16(3):399–406.
   PubMed Web of Science ®Google Scholar
• Poulsen JL, Brock C, Olesen AE, et al. Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction. Clin Exp Gastroenterol. 2014;7:345–358.
   PubMedGoogle Scholar
• Siemens W, Gaertner J, Becker G. Advances in pharmacotherapy for opioid-induced constipation - a systematic review. Expert Opin Pharmacother. 2015;16(4):515–532.
   PubMed Web of Science ®Google Scholar
• Mosinska P, Fichna J, Storr M. Inhibition of ileal bile acid transporter: an emerging therapeutic strategy for chronic idiopathic constipation. World J Gastroenterol: WJG. 2015;21(24):7436–7442.
   PubMed Web of Science ®Google Scholar
• Lacy BE, Levenick JM, Crowell M. Chronic constipation: new diagnostic and treatment approaches. Therap Adv Gastroenterol. 2012;5(4):233–247.
   PubMed Web of Science ®Google Scholar
• Christensen P, Krogh K, Buntzen S, et al. Long-term outcome and safety of transanal irrigation for constipation and fecal incontinence. Dis Colon Rectum. 2009;52(2):286–292.
   PubMed Web of Science ®Google Scholar
• Alessi CA, Henderson CT. Constipation and fecal impaction in the long-term care patient. Clin Geriatr Med. 1988;4(3):571–588.
   PubMedGoogle Scholar
• Bowers B. Evaluating the evidence for administering phosphate enemas. Br J Nurs. 2006;15(7):378–381.
   PubMedGoogle Scholar
• Mendoza J, Legido J, Rubio S, et al. Systematic review: the adverse effects of sodium phosphate enema. Aliment Pharmacol Ther. 2007;26(1):9–20.
   PubMed Web of Science ®Google Scholar
• Sedaba B, Azanza JR, Campanero MA, et al. Effects of a 250-mL enema containing sodium phosphate on electrolyte concentrations in healthy volunteers: an open-label, randomized, controlled, two-period, crossover clinical trial. Curr Ther Res Clin Exp. 2006;67(5):334–349.
   PubMed Web of Science ®Google Scholar
• de Giorgio R, Ruggeri E, Stanghellini V, et al. Chronic constipation in the elderly: a primer for the gastroenterologist. BMC Gastroenterol. 2015;15(1):130.
   PubMed Web of Science ®Google Scholar
• Vilke GM, DeMers G, Patel N, et al. Safety and efficacy of milk and molasses enemas in the emergency department. J Emerg Med. 2015;48(6):667–670.
   PubMed Web of Science ®Google Scholar
• Guideline on the evaluation of medicinal products for the treatment of chronic constipation. European Med Agency. 2014. [Cited 30 Jul 2017]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2009/12/WC500018443.pdf.
   Google Scholar
• Fong SY, Gao Q, Zuo Z. Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review. Evid Based Complement Alternat Med. 2013;2013:898261.
   PubMed Web of Science ®Google Scholar
• Community herbal monograph on psyllium seed European Medicines Agency evaluation of medicines for human use. 2005
   Google Scholar
• Wang MT, Li IH, Lee WJ, et al. Exposure to sennoside-digoxin interaction and risk of digoxin toxicity: a population-based nested case-control study. Eur J Heart Fail. 2011;13(11):1238–1243.
   PubMed Web of Science ®Google Scholar
• Tolman KG, Hammar S, Sannella JJ. Possible hepatotoxicity of doxidan. Ann Intern Med. 1976;84(3):290–292.
   PubMed Web of Science ®Google Scholar
• Chey W, Shiff S, Schneier H, et al. Two years on linaclotide: tolerability and treatment satisfaction in IBS-C patients with and without diarrhea. Am J Gastroenterol. 2014;109(2):1111.
   Google Scholar
• Roerig JL, Steffen KJ, Mitchell JE, et al. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010;70(12):1487–1503.
   PubMed Web of Science ®Google Scholar
• Mearin F, Ciriza C, Minguez M, et al. Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig. 2016;108(6):332–363.
   PubMed Web of Science ®Google Scholar
• Neri I, Blasi I, Castro P, et al. Polyethylene glycol electrolyte solution (Isocolan) for constipation during pregnancy: an observational open-label study. J Midwifery Womens Health. 2004;49(4):355–358.
   PubMed Web of Science ®Google Scholar
• Nardulli G, Limongi F, Sue G, et al. [Use of polyethylene glycol in the treatment of puerperal constipation]. Gen. 1995;49(3):224–226.
   PubMedGoogle Scholar
• Rungsiprakarn P, Laopaiboon M, Sangkomkamhang US, et al. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev. 2015;9:Cd011448.
   PubMed Web of Science ®Google Scholar
• [Cited 2017 Apr 16]. Available from: https://www.aemps.gob.es/cima/dochtml/ft/33581/FichaTecnica_33581.html. 04/16/2017.
   Google Scholar
• [Cited 2017 Apr 16]. Available from: http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/001012/WC500053998.pdf. 04/16/2017.
   Google Scholar
• Li Z, Pergolizzi JV, Huttner RP, et al. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs. J Clin Pharm Ther. 2015;40(6):615–619.
   PubMed Web of Science ®Google Scholar
• [Cited 2017 Apr 20]. Available from: http://www.ema.europa.eu/docs/es_ES/document_library/EPAREPAR_-_Product_Information/human/000870/WC500050562.pdf. 07/12/2017.
   Google Scholar